How Risky Is Organovo Holdings, Inc.?
You probably won't be shocked to learn that Organovo Holdings, Inc. (NASDAQ: ONVO) has historically been a risky stock. After all, the share price of the 3D bioprinting company dropped nearly 36% in 2014 and 66% in 2015, and it's down 23% so far this year. Over the last three and half years, only in 2016 did Organovo stock generate positive returns.
But the company now has products on the market with fast-growing revenue. It has a new CEO at the helm with solid experience. Just how risky is Organovo over the long term?
Image source: Getty Images.
Source: Fool.com
Bristol-Myers Squibb Stock
€39.21
1.590%
Currently there is a rather positive sentiment for Bristol-Myers Squibb with 12 Buy predictions and 3 Sell predictions.
As a result the target price of 70 € shows a very positive potential of 78.55% compared to the current price of 39.21 € for Bristol-Myers Squibb.
